-
Fernandes 'proud' to match Premier League assists record
-
Germany set to miss 2030 climate goal: experts
-
G7 finance chiefs meet to seek common stance on unstable ground
-
Hantavirus-hit cruise ship docks in Rotterdam at voyage end
-
Philippines swears in senators for VP Duterte's impeachment trial
-
Iran's World Cup football team leaves for Turkey: media
-
Hantavirus-hit cruise ship steams towards Rotterdam at voyage end
-
Japan arrests Americans over stunt at baby monkey Punch's zoo
-
Trump says 'clock ticking' for Iran as peace negotiations stall
-
Hong Kong court hears closing arguments in Tiananmen activists' trial
-
World Cup duo Ghana, Cape Verde not among AFCON top seeds
-
African players in Europe: Daring Semenyo wins final for City
-
Kenya's new poaching problem: smuggling Giant Harvester Ants
-
WHO kicks off annual assembly amid hantavirus, Ebola crises
-
S. Korean blockbuster 'Hope' underscores growing film ambition
-
Train driver charged after deadly Bangkok bus collision
-
Angry Chinese table tennis fans demand apology for flag gaffe
-
India's lifeline ferry across strategic archipelago
-
Encroaching world threatens India's last 'uncontacted' tribe
-
India's strategic $9 bn megaport plan for pristine island
-
In Tierra del Fuego, a hunt for the rodent carrier of hantavirus
-
Mitchell leads Cavs past top-seeded Detroit into NBA East finals
-
China's April consumption, factory output growth slowest in years
-
Asian stocks sink, oil rises on US-Iran deadlock
-
Cleveland Cavaliers eliminate top-seeded Detroit from NBA playoffs
-
Who could be the 2026 World Cup's breakout star?
-
Humble PGA champ Rai celebrates English, Indian, Kenyan heritage
-
Hantavirus-hit cruise ship nears end of voyage, to dock in Rotterdam
-
He said, she said, AI said: Wall Street sex scandal rivets and confounds
-
UN General Assembly to take up climate change 'obligations' resolution
-
Four takeaways from Musk vs OpenAI trial
-
Jury to decide fate of Musk's blockbuster suit against OpenAI
-
Frustrated McIlroy drops F-bomb in exchange with PGA heckler
-
Defending champion Palou storms to Indy 500 pole
-
Messi shines as Inter Miami finally win at new stadium
-
Shai Gilgeous-Alexander wins second straight NBA MVP award
-
White House mass prayer event seeks to reclaim US Christian roots
-
International dive group joins Maldives search for missing Italians
-
'Staggering' Iran toll drives up global executions: Amnesty
-
June 29 Marijuana Rescheduling Hearing Faces Constitutional Issues Before It Even Begins
-
Aliko Dangote: African Energy Person of the Year 2026
-
Agronomics Limited Announces Net Asset Value Calculation as at 31 March 2026
-
Santa Barbara Schools Sexual Assault Complaint by Veen Firm
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 18
-
Rai wins first major at PGA with back-nine birdie blitz
-
Woad bags second LPGA title at Queen City Championship
-
Lebanon says Israeli strikes kill 7 as Hezbollah condemns talks
-
Revived La Rochelle trounce Top 14 leaders Toulouse
-
PSG beaten by Paris FC in Ligue 1 as Lille qualify for Champions League
-
Griezmann apologetic on emotional Atletico Madrid farewell
Japan approves abortion pill for the first time
The abortion pill will become available in Japan for the first time after the health ministry approved the drug used to terminate early-stage pregnancy.
Abortion is legal in Japan up to 22 weeks but consent is usually required from a spouse or partner, and until now a surgical procedure had been the only option.
The ministry said in a notification to healthcare officials on Friday it had approved the drug made by British pharmaceutical company Linepharma.
The drugmaker filed its product, a two-step treatment of mifepristone and misoprostol, for approval in Japan in December 2021.
Similar medication is available in many countries including France, which first approved the abortion pill in 1988, and the United States, where it has been available since 2000.
The approval of the pill to end pregnancies up to nine weeks follows a ministry panel endorsement, which was postponed for a month as thousands of public opinions were submitted.
National broadcaster NHK said the total cost of the abortion pill and a medical consultation would be around 100,000 yen ($700). Abortions are not covered by public health insurance.
Surgical abortions can cost around 100,000 to 200,000 yen.
Mifepristone has been at the centre of a high-profile US court battle in recent weeks.
The US Supreme Court has temporarily preserved access to the widely used abortion drug, freezing rulings by lower courts that would have banned or severely restricted its availability.
Campaigners in Japan are also pushing for better access to the morning-after pill, which prevents pregnancy.
Emergency contraception cannot currently be bought in Japan without a doctor's approval. It is also the only medicine that must be taken in front of a pharmacist to stop it being sold on the black market.
C.Garcia--AMWN